Literature DB >> 26933170

Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.

Wei Chen1, Jin Kyu Yi2, Tetsu Shimane1, Shebli Mehrazarin1, Yi-Ling Lin1, Ki-Hyuk Shin3, Reuben H Kim3, No-Hee Park4, Mo K Kang5.   

Abstract

Grainyhead-like 2 (GRHL2) is one of the three mammalian homologues of Drosophila Grainyhead involved in epithelial morphogenesis. We recently showed that GRHL2 also controls normal epithelial cell proliferation and differentiation. In this study, we investigated the role of GRHL2 in oral carcinogenesis and the underlying mechanism. GRHL2 expression was elevated in cells and tissues of oral squamous cell carcinomas (OSCCs) compared with normal counterparts. Knockdown of GRHL2 resulted in the loss of in vivo tumorigenicity, cancer stemness and epithelial phenotype of oral cancer cells. GRHL2 loss also inhibited oral cancer cell proliferation and colony formation. GRHL2 regulated the expression of miR-200 family and Octamer-binding transcription factor 4 (Oct-4) genes through direct promoter DNA binding. Overexpression of miR-200 genes in the oral cancer cells depleted of GRHL2 partially restored the epithelial phenotype, proliferative rate and cancer stemness, indicating that miR-200 genes in part mediate the functional effects of GRHL2. Taken together, this study demonstrates a novel connection between GRHL2 and miR-200, and supports protumorigenic effect of GRHL2 on OSCCs.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26933170      PMCID: PMC6118232          DOI: 10.1093/carcin/bgw027

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  37 in total

1.  Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.

Authors:  Benjamin Cieply; Philip Riley; Phillip M Pifer; Joseph Widmeyer; Joseph B Addison; Alexey V Ivanov; James Denvir; Steven M Frisch
Journal:  Cancer Res       Date:  2012-02-29       Impact factor: 12.701

2.  Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.

Authors:  Toni Celià-Terrassa; Oscar Meca-Cortés; Francesca Mateo; Alexia Martínez de Paz; Nuria Rubio; Anna Arnal-Estapé; Brian J Ell; Raquel Bermudo; Alba Díaz; Marta Guerra-Rebollo; Juan José Lozano; Conchi Estarás; Catalina Ulloa; Daniel Álvarez-Simón; Jordi Milà; Ramón Vilella; Rosanna Paciucci; Marian Martínez-Balbás; Antonio García de Herreros; Roger R Gomis; Yibin Kang; Jerónimo Blanco; Pedro L Fernández; Timothy M Thomson
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

Review 3.  The cancer stem cell: premises, promises and challenges.

Authors:  Hans Clevers
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

4.  Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.

Authors:  Stefan Werner; Sabrina Frey; Sabine Riethdorf; Christian Schulze; Malik Alawi; Lea Kling; Vida Vafaizadeh; Guido Sauter; Luigi Terracciano; Udo Schumacher; Klaus Pantel; Volker Assmann
Journal:  J Biol Chem       Date:  2013-06-29       Impact factor: 5.157

Review 5.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

6.  Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.

Authors:  Yasuo Tanaka; Fumihiko Kanai; Motohisa Tada; Ryosuke Tateishi; Masashi Sanada; Yasuhito Nannya; Miki Ohta; Yoshinari Asaoka; Motoko Seto; Shuichiro Shiina; Haruhiko Yoshida; Takao Kawabe; Osamu Yokosuka; Seishi Ogawa; Masao Omata
Journal:  J Hepatol       Date:  2008-07-09       Impact factor: 25.083

7.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

8.  Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival.

Authors:  M K Kang; R H Kim; S J Kim; F K Yip; K-H Shin; G P Dimri; R Christensen; T Han; N-H Park
Journal:  Br J Cancer       Date:  2006-12-19       Impact factor: 7.640

9.  Immunocytochemistry and laser capture microdissection for real-time quantitative PCR identify hindbrain neurons activated by interaction between leptin and cholecystokinin.

Authors:  Diana L Williams; Michael W Schwartz; L Scot Bastian; James E Blevins; Denis G Baskin
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

10.  Grainy head promotes expression of septate junction proteins and influences epithelial morphogenesis.

Authors:  Maithreyi Narasimha; Anne Uv; Alena Krejci; Nicholas H Brown; Sarah J Bray
Journal:  J Cell Sci       Date:  2008-02-26       Impact factor: 5.285

View more
  24 in total

Review 1.  Roles of Grainyhead-like transcription factors in cancer.

Authors:  S M Frisch; J C Farris; P M Pifer
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

2.  Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.

Authors:  Adnen Faddaoui; Razan Sheta; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Stephane Gobeil; Chantale Morin; Karim Ghani; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

Review 3.  Grainyhead-like transcription factors in cancer - Focus on recent developments.

Authors:  Grzegorz Kotarba; Agnieszka Taracha-Wisniewska; Tomasz Wilanowski
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-02

4.  Porphyromonas gingivalis Impairs Oral Epithelial Barrier through Targeting GRHL2.

Authors:  W Chen; A Alshaikh; S Kim; J Kim; C Chun; S Mehrazarin; J Lee; R Lux; R H Kim; K H Shin; N H Park; K Walentin; K M Schmidt-Ott; M K Kang
Journal:  J Dent Res       Date:  2019-07-24       Impact factor: 6.116

5.  Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.

Authors:  Steve Paltoglou; Rajdeep Das; Scott L Townley; Theresa E Hickey; Gerard A Tarulli; Isabel Coutinho; Rayzel Fernandes; Adrienne R Hanson; Iza Denis; Jason S Carroll; Scott M Dehm; Ganesh V Raj; Stephen R Plymate; Wayne D Tilley; Luke A Selth
Journal:  Cancer Res       Date:  2017-05-04       Impact factor: 12.701

Review 6.  Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis.

Authors:  Xueqian Zhuang; Hao Zhang; Guohong Hu
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

7.  GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression.

Authors:  Rebecca M Reese; Kyle T Helzer; Kaelyn O Allen; Christy Zheng; Natalia Solodin; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2022-08-29       Impact factor: 5.069

8.  Identification of a novel progenitor cell marker, grainyhead-like 2 in the developing pituitary.

Authors:  Whitney Edwards; Leah B Nantie; Lori T Raetzman
Journal:  Dev Dyn       Date:  2016-09-18       Impact factor: 3.780

Review 9.  Grainyhead-like 2 as a double-edged sword in development and cancer.

Authors:  Jiaxing He; Chunyang Feng; He Zhu; Shuying Wu; Peng Jin; Tianmin Xu
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

10.  GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer.

Authors:  Xiang Pan; Rong Zhang; Caifeng Xie; Mingxi Gan; Sheng Yao; Yubin Yao; Jiangbo Jin; Tianyu Han; Yunhe Huang; Yanlong Gong; Jianbin Wang; Bentong Yu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.